Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE (0.60%), DAX (0.33%), CAC40 (0.29%)

Oct 27 ,2026

  • Synopsis

    • European equity market are set to open lower, following Monday's firmer close. Asian equity markets mixed. Nikkei and Kospi seeing strong gains, but weakness in China markets. ASX records modest gains.

    • European equity markets defensive despite positive momentum in Asia from AI trade, with memory and chip equipment names leading. Anthropic's pre-IPO filing the focus after revealing 1300% lift in H1 revenue. Company disclosed $77B in financing commitments from Amazon, Broadcom, and Google. Also helping support capex narrative was Meta's $95B equity raise and SpaceX's $40B debt deal to finance Nvidia GPU acquisition. Comes ahead of Alphabet, Microsoft and Amazon's earnings this week, which are expected to favorable monetization dynamics.

    • Investors looking through latest Middle East developments. Crude has pulled back a bit from recent highs on hopes for a diplomatic solution to US-Iran tensions. Senior officials from Saudi Arabia, Turkey and Pakistan met Iranian leaders in Tehran on Monday to reduce tensions. However, expectations for a resumption of kinetic action after November midterms continue to build with elections only a week away. Press have highlighted how US forces are ready to launch major combat operations while Iran has threatened to strike a wide array of targets across Middle East if it is attacked.

    • Also on today's agenda, in central banks, Bundesbank's Köhler-Geib and Mauderer speeches at 10:35CET and 15:30 respectively, at AI Week Frankfurt. In the UK, parliamentary committee topics include the future of farming at 10:00GMT and entrepreneurship and business at 14:30. Norway's PM Støre as well as ministers for foreign affairs Eide and for cooperation Aukrust attend the Nordic Council session in Helsinki (through Wed). Meeting of EU agriculture and fisheries ministers (through Tue), EU's Hansen among the attendees. EU's Šefčovič meets with ECB's Lagarde at 18:00CET for an informal dinner and exchange of views. Chancellor Merz will hold talks in Singapore with PM Wong. A meeting with President Shanmugaratnam is also planned. In addition, the Chancellor will deliver a speech as part of the Singapore Lecture. S&P Ratings webinar at 14:00GMT title European banking insights: Neobanks, AI trends and bank capitalization.

    • On macro data front, BRC's UK shop price measure hit highest level in two years due to higher energy and transport costs. ECB M3 money supply and loan growth data out later. In other news, French President Macron offers students funding and reforms to end protests. Spain eases rules for data center power usage. Ahead of Wednesday's UK Budget, reports said Chancellor Healey to raise national living wage by ~4% but will not close gap with young workers to ease cost of hiring for business. BBC reported that Healey will also remove import tax on up to 100 products to ease cost of living for families.

    • In earnings news, In the DACHs region Novartis (NOVN.SW), Porsche (P911.GR), and SIG Combibloc Group (SIGN.SW) posted earnings this morning, with the latter delivering presentation in connection with it's CMD. In France, Orange (ORA.FP) released Q3 earnings beating consensus with EBITDAaL of €4.14B and raised its FY EBITDAaL growth guidance to exceeding +4.5%. In the UK, HSBC Holdings (HSBA.LN) issues Q3 earnings numbers with an EPS of $0.41 and approved a $0.10/share interim dividend while initiating a $1B share buyback. In Nordics, Vend Marketplaces (VEND.NO), Wartsila (WRT1V.FH) and Alfa Laval (ALFA.SS) are amongst others in the region to report earnings today.

  • Politics/Macro/World News

    • Geopolitics

      • Israel heads to polls for pivotal election defined by security and democracy - BBC

      • Saudi defence pact countries push for peace in Tehran as Houthis launch more attacks - Reuters

    • EU

      • Tobacco lobby steps up Brussels push as EU rewrites rules - Politico

    • UK

      • Healey to increase minimum wage but slow rise for young people - The Times

      • Britain in talks with EU over free movement - The Telegraph

      • UK Oct shop price inflation +2.1% vs consensus +1.6% and prior +1.4% - BRC

    • France

      • France must appease protesters without extra spending, says finance minister - FT

    • Germany

      • Green electricity subsidy requirement in 2027 one billion higher than planned - Handelsblatt

  • Top company news

    • Earnings/updates

      • DACHs

        • NOVN.SW (Novartis) -- reports Q3 core EPS $2.46 vs consensus $2.29; raises FY26 guidance for core operating income

        • SIGN.SW (SIG Combibloc Group) -- reports Q3 adjusted net income €94.3M vs FactSet €81.5M; raises FY EBIT margin range guidance

        • SIGN.SW (SIG Combibloc Group) -- updates mid-term financial targets: +3-5% organic revenue growth and adj. EBIT margin above 18% - CMD

        • IFCN.SW (Inficon Holding) -- reports Q3 EPS $1.94 vs FactSet $1.02 [1 est]; raises FY guidance

        • COK.GR (CANCOM) -- reports preliminary Q3 EBITA €10.8M vs year-ago €13.4M; lowers revenue forecast for the current financial year 2026

        • BUCN.SW (Bucher Industries) -- reports 9M revenue CHF2.10B, (3%) vs year-ago CHF2.16B

        • HYQ.GR (Hypoport) -- expected results for Q3/26 and Q1-Q3/26:

        • CEC.GR (CECONOMY) -- reports prelim FY EBIT ~€515M vs FactSet €486.5M [3 est, €451-509.6M]

        • BSLN.SW (Basilea Pharmaceutica) -- lifts FY26 guidance; also raises Cumulative cash flow target for "Agenda 2030" ; updates on late-stage clinical programs ahead of 28-Oct CMD

        • P911.GR (Porsche) -- reports 9M EPS €2.06 vs year-ago €0.13; confirms its FY26 forecast

      • Nordics

        • VEND.NO (Vend Marketplaces) -- reports Q3 EPS cont ops NOK21.26 vs year-ago (NOK3.50)

        • TIETO.FH (Tieto Corporation) -- reports preliminary Q3 revenue €389.6M vs prior guidance €400M and FactSet €399.2M [10 est, €383.7-416.7M]

        • ELO.NO (Elopak) -- reports Q3 EPS €0.09 vs FactSet €0.07 [6 est, €0.07-0.08]

        • SATS.NO (SATS ASA) -- reports Q3 EPS NOK0.69 vs FactSet NOK0.61 [7 est, NOK0.50-0.68]

        • PUBLI.NO (Ppi Public Property Invest AB) -- reports Q3 EPRA EPS SEK 0.29 vs year-ago SEK 0.21

        • KCC.NO (Klaveness Combination Carriers) -- reports Q3 EPS $0.40 vs FactSet $0.40 [5 est, $0.37-0.43]

        • ALFA.SS (Alfa Laval)-- reports Q3 EPS SEK5.40 vs FactSet SEK5.70 [14 est, SEK5.30-6.24]

        • WRT1V.FH (Wartsila) -- reports Q3 EPS, continuing ops, €0.28 vs consensus €0.24

        • GOFORE.FH (Gofore) -- reports Q3 EPS €0.24 vs FactSet €0.15 [2 est, €0.14-0.16]

        • HANZA.SS (HANZA AB) -- reports Q3 EPS SEK1.90 ex-items vs FactSet SEK1.61 [3 est, SEK1.52-1.70]

        • WRT1V.FH (Wärtsilä) -- announces new mid-term financial targets; moves to a new guidance practice in 2027; holding Capital Markets Day on 3-Nov-26

      • Benelux

        • PHARM.NA (Pharming Group) -- reports Q3 EPS $0.03 vs FactSet $0.02 [3 est, $0.00-0.04]

      • France

        • EXENS.FP (Exosens) -- reports Q3 revenue €133.8M vs FactSet €132.4M [4 est, €123-140M]

        • ORA.FP (Orange) -- reports Q3 EBITDAaL €4.14B vs consensus €4.10B; raises FY EBITDAaL growth guidance to exceeding +4.5% vs prior guidance above +4%

      • UK

        • HSBA.LN (HSBC Holdings) -- reports Q3 EPS $0.41 vs consensus $0.42

      • Also due to report today:

        • Earnings:

          • Benelux: ASM International (ASM.NA)

          • Finland: Nokian Renkaat (TYRES.FH), Vaisala (VAIAS.FH), GRK Infra (GRK.FH), Finnair (FIA1S.FH)

          • France: Verallia (VRLA.FP)

          • Germany: Villeroy & Boch (VIB3.GR)

          • Italy: MAIRE (MAIRE.IM)

          • Sweden: Assa Abloy (ASSA.B.SS), Swedish Orphan Biovitrum (SOBI.SS), Storytel (STORY.B.SS), VBG Group (VBG.B.SS),VNV Global (VNV.SS), CTT Systems (CTT.SS), Prevas (PREV.B.SS), Dedicare (DEDI.SS)

          • Spain: Ferrovial (FER.SM), ENCE Energia y Celulosa (ENC.SM)

          • Switzerland: Temenos (TEMN.SW)

          • UK: Standard Chartered (STAN.LN), Ultimate Products (ULTP.LN)

        • Trading Update:

          • France: Compagnie de Saint-Gobain (SGO.FP), Alten (ATE.FP), Compagnie des Alpes (CDA.FP), Worldline (WLN.FP), Linedata Services (LIN.FP), Deezer (DEEZR.FP), Haulotte Group (PIG.FP)

          • Germany: Beiersdorf (BEI.GR)

          • Nordics: Digia (DIGIA.FH)

          • UK: Reckitt Benckiser (RKT.LN), Luceco (LUCE.LN)

        • CMD/Events: Gubra (GUBRA.DC) R&D Day, Greencoat UK Wind (UKW.LN) business update call

    • M&A

      • BESI.NA (BE Semiconductor Industries) -- Applied Materials to increase its strategic investment in BE Semiconductor Industries to ~20% of Besi's outstanding shares

      • IVG.IM (Iveco Group) -- TML CV reports provisional results from tender offer indicate threshold condition for acquisition of Invesco has been satisfied

      • FDE.FP (La Française de l'Energie) -- to sell its entire 56.04% interest in Elgane Vind AS to Zephyr AS for consideration up to NOK 4M (c. €0.34 M)

    • Healthcare

      • PFE (Pfizer) -- FDA approves Talzenna for metastatic hormone-sensitive prostate cancer

      • LLY (Eli Lilly) -- Court rules for Eli Lilly in Novo suit over obesity drug ads - Reuters

      • AZN.LN (AstraZeneca) -- Transcript Intelligence: AstraZeneca at European Society for Medical Oncology Congress

      • BAYN.GR (Bayer AG) -- Bayer shares new post hoc analysis on Lynkuet in women with moderate to severe vasomotor symptoms

      • IDIA.SW (Idorsia) -- announces first patients enrolled in Dari-Dream, a US label-enabling study evaluating QUVIVIQ (daridorexant) 50 mg in adults and elderly people with insomnia disorder

      • PPGN.SW (PolyPeptide Group) -- elects John Chongbo Rim as chair of the board

    • Other

      • BBVA.SM (Banco Bilbao Vizcaya Argentaria) -- reports the minimum prudential capital requirements for 2027 required by the ECB (post EU close 26-Oct)

      • BESI.NA (BE Semiconductor Industries) -- completes €60M share repurchase program; new €100M share repurchase program initiated

      • CABK.SM (CaixaBank) -- reports information about the minimum capital requirements for 2027 (post EU close 26-Oct)

      • SUN.SW (Sulzer) -- and PDVSA sign long-term strategic alliance agreement

      • SAB.SM (Banco de Sabadell) -- reports the minimum prudential capital requirements for 2027 required by the ECB (post EU close 26-Oct)

      • UNI.IM (Unipol Gruppo) -- announces result of rights issue; ~98.42% of shares offered subscribed (post EU close 26-Oct)

      • LAND.SW (Landis+Gyr Group) -- Landis+Gyr secures "major" contract with US utility

  • Key rating changes

    • Upgrades

      • ANTO.LN (Antofagasta) -- to hold from sell at Deutsche Bank

      • ELUX.B.SS (Electrolux) -- to buy from hold at DNB Carnegie

    • Downgrades

      • RCO.FP (Remy Cointreau) -- to market perform from outperform at Bernstein

    • Initiations

      • SCYR.SM (Sacyr Vallehermoso) -- outperform at Oddo

  • Data

    • Nikkei +1.73% to 63268.37

    • Hang Seng (0.61%) to 23070.99

    • Shanghai Composite (0.69%) to 3671.95

    • S&P futures (5.8) vs prior close of 7714.5

    • €-$ (0.0014) or (0.13%) to 1.1162

    • $-¥ +0.29 or +0.18% to 157.79

    • €-¥ +0.12 or +0.07% to 176.11

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.